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pendulous breasts
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Letizia Deantonio1,3, Marco Brambilla2 and Giuseppina Gambaro1Abstract
Purpose: To analyze dosimetric parameters of patients receiving adjuvant breast radiotherapy (RT) in the prone
versus supine position.
Methods and materials: Forty-one out of 55 patients with pendulous breasts and candidates for adjuvant RT were
enrolled in the study after informed consent. They underwent computed tomography (CT)-simulation in both prone
and supine position. Target and non target volumes were outlined on CT images. Prescribed dose was 50 Gy delivered
by two tangential photon fields followed by 10 Gy electron boost. Target coverage and dose homogeneity to clinical
target volume (CTV) and planning target volume (PTV) were assessed by V95, V105 and V107 and dose to lung, heart
and left anterior descending coronary artery (LAD) by V5, V10, V20, and mean and maximum dose. Data were analyzed
by Student’s t-test.
Results: CTV and PTV coverage was significantly better in supine than in prone position. Lung V5, V10, and V20 were
significantly lower in prone than in supine position. Heart V5, V10, V20, and LAD mean and maximum dose, in the 17
patients with left breast tumor, were lower in prone than in supine position, but without statistical significance. Based
on treatment planning data and on treatment feasibility, 29/41 patients (70.7%) were treated in prone position. Acute
and late toxicities of patients treated in prone and in supine position were not statistically different.
Conclusion: Prone position is a favorable alternative for irradiation of mammary gland in patients with pendulous
breasts and in our series was adopted in 71% of the cases.
Keywords: Breast cancer, Prone setup, Dosimetric analysisBackground
The majority of patients with early-stage breast cancer
are candidates for breast-conservation therapy followed
by whole-breast irradiation (WBI), typically delivered in
the supine position. However, supine WBI does have
limitations such as lateral dislocation of breast, accentu-
ation of the infra-mammary folds, and inclusion of lung
and heart portion in treatment plan. In particular, irradi-
ation after breast-conserving surgery (BCS) in women
with large and/or pendulous breasts is a challenge for* Correspondence: krengli@med.unipmn.it
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reproduction in any medium, provided the orradiation oncologists. Increased radiation related toxicity
and worse cosmetic outcome was found in patients with
large breasts and/or increased body mass index (BMI)
[1]. Radiation factors identified as potentially causative
include increased dose inhomogeneity from medial to
lateral separation of the breast and bolus effect on skin,
in the infra-mammary folds, where there is increased
skin-on-skin contact. In addition, patients may receive
increased doses to critical structures such as the heart or
lungs owing to the positioning of the breast on the chest
wall when the patient lies supine. Prone breast irradi-
ation aims to improve some of the technical limitations
associated with treating large and pendulous breasts and
it may limit radiation doses to organs at risk such as
lung and heart [2-4].Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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three dimensional conformal radiotherapy (3D-CRT) in
the prone position to address the technical challenges
associated with irradiation of large and pendulous breasts.
The goal of this study is to compare dosimetric parame-
ters in prone versus supine position in a cohort of women
with pendulous breasts receiving WBI with two tangential
fields after conservative surgery.
Methods
Fifty-five consecutive patients presenting with pendulous
breasts were selected for this prospective study after
BCS at our institution. Selection of patients was based
on the presence of the typical infra-mammary fold in su-
pine position and on the technical feasibility of the
simulation procedure considering the gantry diameter of
70 cm of the helical computed tomography (CT)-scan
(Prospeed, General Electric, Milwaukee, USA). The indi-
cation of regional node irradiation was an exclusion
criteria. The informed consent was obtained in all cases.
CT simulation was performed in both prone and su-
pine position with contiguous slices of 5 mm thickness
covering the entire thoracic region from the apex of the
lung to the diaphragm. In the prone setup, the patient
was positioned on the breast board Clear Vue™ (Orbital
Therapy, Bedford, USA) with both arms above the head
and the hands holding a handlebar to reduce body rota-
tion. The contralateral breast was lifted away from the
treated breast and placed on the top of the mattress.
The head was turned away from the treated side. At the
time of CT simulation, a posterior-anterior setup point
was established and 4 leveling markers on the skin two
on the midline in the dorsal region, one at the level of
the lower aspect of the scapula and one at the level of
the mid-axillary line. Supine patient setup was secured
by the breast Posiboard™ system (CIVCO, Kalona, USA).
Three skin markers, two on the midline in the sternal
region and one in the lateral aspect of the breast, were
placed for position verification.
The following target and non-target structures were
outlined: clinical target volume (CTV), planning targetFigure 1 Treatment plans in supine (right) and prone (left) setup.volumes (PTV), ipsilateral lung, heart, and left anterior
descending coronary artery (LAD). CTV was defined as
the entire breast tissue starting 5 mm below the skin.
PTV was obtained by adding 10 mm margin to the
CTV, except in the skin direction.
Treatment technique consisted of two opposed tan-
gential fields by using 6–15 MV photon beams (Figure 1).
Radiation fields were appropriately customized by multi-
leaf collimator when needed in order to spare the sur-
rounding healthy tissues. The angle of the beams was
adjusted to minimize the irradiation of lung parenchyma
and left ventricle. Appropriate physical wedge compen-
sation was used to achieve optimal target coverage and
minimize dose heterogeneity. Total dose prescribed was
50 Gy in 25 fractions delivered by the two tangential
fields in supine or prone position followed by 10 Gy
boost dose in 5 fractions to the tumor bed, delivered by
electrons in supine position.
At the first treatment session, portal images of the two
tangential treatment fields were acquired and compared
with the treatment plan digitally reconstructed radio-
graphs. At the same time, a reference surface image of
the thorax was recorded by the AlignRT™ system
(VisionRT, London, UK). Surface images were acquired
daily during every setup procedure and co-registered
with the reference image obtained at the first treatment
session.
Dose calculation with a grid of 3 mm was performed
using the collapsed cone convolution algorithm of the
treatment planning system, including the correction for
tissue heterogeneity. Dose volume histograms (DVHs)
for CTV, PTV, ipsilateral lung and heart and LAD were
calculated.
Two treatment plans were performed for each case in
prone and in supine position respectively. Priority was
given to target coverage taking into account our dose
limitation for lung parenchyma (V20 < 10%) and heart
(V5 < 5%) for this specific treatment with two tangential
fields.
CTV and PTV coverage was analyzed by using the vol-
ume receiving at least 95% (V95), 105% (V105), and
Table 1 Main patients characteristics
Characteristics Parameters Values
Age Mean 54.9
Median 55
Range 30-74
Karnofsky Performance
Status
Median 90
Range 80–100
Body Mass Index Mean 24.3
Median 24
Range 20-32
Breast Side Right 24 (58.5%)
Left 17 (41.5%)
Pathological Tumor Stage Tis 2 (4.9%)
T1 29 (70.7%)
T2 10 (24.4%)
Pathological Nodal Stage N0 28 (68.3%)
N1 13 (31.7%)
Surgery Conservative surgery + biopsy
of sentinel node
28 (68.3%)
Conservative surgery + axillary
node dissection
13 (31.7%)
Histology Ductal infiltring carcinoma 31 (75.6%)
Lobular infiltring carcinoma 5 (12.2%)
Mixed carcinoma 3 (7.3%)
In-situ ductal carcinoma 2 (4.9%)
Estrogen/Progesteron
Receptors
Positive 27 (65.9%)
Negative 14 (34.1%)
Anti-Hormone Therapy Yes 19 (46.3%)
No 22 (53.7%)
Adjuvant Chemotherapy Yes 10 (24.4%)
No 31 (75.6%)
Optimal Position Prone 29 (70.7%)
Supine 12 (29.3%)
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LAD were analyzed by maximum (Dmax) and mean
dose (Dmean), V5, V10, and V20. Statistical analysis
was performed with Student’s t-test considering a
p value <0.05 as statistically significant. Acute and late
toxicity were scored using the Radiation Therapy Oncol-
ogy Group criteria [5]. Acute toxicity was assessed weekly
during treatment and monthly after treatment comple-
tion. Late effects were assessed during follow-up visits
6 months after radiotherapy, every 4 months for the first
2 years and every 6 months. The incidence in the two
patient groups was analyzed by Fisher’s exact test.
Results
Forty-one of the 55 (74.5%) selected patients with pen-
dulous breasts were effectively enrolled in our prospect-
ive study. All patients presented with infra-mammary
fold with potential bolus effect on the skin when laying
in supine position. Fourteen patients (25.4%) with larger
breasts were excluded because of the insufficient gantry
diameter of CT-scan (12 patients, 21.8%) or of the low
compliance to prone setup position (2 patients, 3.6%).
The main patients characteristics are summarized in
Table 1.
The results of the dosimetry comparison of the two
setup positions for the whole series and for left sided
tumors are summarized in Tables 2 and 3.
Target coverage, assessed by V95, V105 and V107 of
CTV and PTV, is reported in Table 2.
The ipsilateral lung received less dose in prone than in
supine position in all cases. The, V20, V10, and V5 as
well as Dmean and Dmax resulted significantly lower in
prone position (Table 2 and Figure 2).
A trend was evident in heart Dmax between the two
setup positions in the 17 left sided breast cancers
(Table 3). In 4/17 cases (23.5%), dose to the heart was
higher in prone than in supine position. Dmax and
Dmean to LAD in prone position resulted non-
significantly lower in left sided breast cancers.
Considering target coverage and dose constraints to
the healthy structures, 29 of the 41 patients (70.7%) in-
cluded in the study were actually treated in prone setup
because the treatment plan allowed a better sparing of
lung and heart. Twelve patients (29.3%) were treated in
supine position: 6 because of the inadequate target
coverage in prone position in cases with extremely
lateralized lesions, 2 because of the better dose homo-
geneity (smaller hot spots V105 and V107), 3 because of
the lower dose to the heart in cases with medial lesions,
and one because of the unfavorable geometry of treat-
ment in prone position leading to a gantry versus breast
board collision.
All the 29 patients treated with prone setup had an ad-
vantage in terms of dose to the lung (p<10-6 for allparameters) and the 10/17 patients (58.8%) with left-
sided cancers had an advantage in all dosimetric param-
eters of the heart and the Dmean and Dmax of the LAD
(Tables 3 and 4).
As far as the treatment reproducibility, data about the
prone setup by using portal imaging checks showed me-
dian inter-fraction differences of 2.0 mm, 1.8 mm, and
2.5 mm in latero-lateral, longitudinal, and vertical axes
respectively, similar to the data previously published for
the supine position [6].
As far as acute toxicity, 18/41 of patients (43.9%) de-
veloped grade 1 and 19 (46.3%) developed grade 2
dermatitis consisting of moderate to brisk erythema, skin
desquamation, typically located in the infra-mammary
skin fold. Grade 3 acute dermatitis was observed in 4
Table 2 Comparison of dosimetric parameters from
treatment plans obtained in the two setup positions for
the whole patients series (41 patients)
Prone setup Supine setup p-value
PTV (cc) 534.9 ± 229.4 515.3 ± 174.2 0.32
V95 (%) 96.5 ± 3.5 98.0 ± 1.6 0.04
V105 (%) 1.4 ± 1.1 2.0 ± 2.5 0.14
V107 (%) 0.1 ± 0.2 0.2 ± 0.5 0.16
Dmin (Gy) 35.8 ± 11.3 35.8 ± 10.2 0.97
Dmax (Gy) 53.7 ± 0.6 53.7 ± 0.6 0.80
Dmean (Gy) 50.1 ± 0.4 50.1 ± 0.3 0.42
CTV (cc) 468.1 ± 216.6 432.0 ± 159.0 0.02
V95 (%) 98.4 ± 2.3 99.3 ± 1.0 0.02
V105 (%) 1.3 ± 1.1 1.8 ± 2.4 0.25
V107 (%) 0.1 ± 0.2 0.1 ± 0.4 0.45
Dmin (Gy) 42.4 ± 7.4 44.4 ± 4.4 0.15
Dmax (Gy) 53.6 ± 0.6 53.5 ± 0.6 0.42
Dmean (Gy) 50.2 ± 0.4 50.2 ± 0.3 0.92
Lung (cc) 1335.0 ± 331.0 1201.0 ± 264.0 <10-6
V20 (%) 1.5 ± 1.8 9.0 ± 3.4 <10-6
V10 (%) 2.6 ± 2.4 12.7 ± 4.3 <10-6
V5 (%) 4.0 ± 3.2 18.4 ± 5.3 <10-6
Dmean (Gy) 1.4 ± 0.9 5.2 ± 1.5 <10-6
Dmax (Gy) 39.7 ± 12.4 49.5 ± 1.7 <10-5
PTV, planning target volume; CTV, clinical target volume.
Table 3 Comparison of heart and left anterior descending
coronary artery (LAD) dosimetric parameters in the two
setup positions for the 17/41 patients with left breast
cancer
Prone setup Supine setup p-value
Heart (cc) 438.3 ± 79.5 465.3 ± 90.3 0.09
V20 (%) 1.5 ± 2.2 1.5 ± 1.5 0.90
V10 (%) 2.3 ± 2.8 2.6 ± 2.4 0.64
V5 (%) 4.0 ± 4.1 4.6 ± 3.9 0.59
Dmean (Gy) 1.9 ± 1.3 2.0 ± 1.0 0.95
Dmax (Gy) 36.8 ± 12.5 41.9 ± 9.8 0.06
Dmean LAD (Gy) 11.8 ± 9.8 12.0 ± 9.1 0.95
Dmax LAD (Gy) 27.8 ± 16.0 33.0 ± 13.2 0.14
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desquamation.
After 22.9 months mean follow-up (range: 12.1 -
52.3 months; median 17.5), late toxicity consisting of
grade fibrosis 1 was found in 12/41 patients (29.3%). No
significant difference was observed between the patients
treated in prone and supine position either for acute or
late toxicity. Looking at the occurrence of moist des-
quamation, there was a favorable trend (p=0.05) for
patients treated in prone position.
Discussion
The first study reporting a similar disease local control
and toxicity in prone and supine treatment of breast
with an evident reduction in lung and heart volumes in-
side treatment fields was conducted at Memorial Sloan
Kettering Cancer Center in 1992 (2). The authors also
demonstrated a reduction in dose inhomogeneity by ap-
proximately 15% compared with supine tangents in
women with pendulous breasts. Subsequently, several
studies showed advantages of the prone position include
a more homogenous dose distribution with a reduction
in the size of the hot spots, resulting in decreased acute
reactions, irradiation of less normal tissue, and improved
setup reproducibility [7-11]. A recent study showed that,the prone position was better than the supine position
for sparing the lung and for sparing the heart in the ma-
jority of left breast cancer patients, especially in case of
large breasts [12].
In our study, we analyzed women with smaller breasts
and lower BMI compared to other US and North Europe
series showing that prone position can be advantageous
also in this group of patients and not only in case of very
large breasts [11,13,14].
Some authors observed that in prone position, the bet-
ter breast shape associated with lower thorax respiratory
movements may reduce hot spots inside PTV with con-
sequently better cosmetic result [2]. Six patients with ex-
tremely lateralized lesions had an inadequate coverage of
PTV and CTV with prone setup, documented by V95,
and consequently were treated in supine position. In this
regard, other authors published data indicating a worst
PTV coverage in extremely medially or laterally located
lesions [15].
About lung reduction dose in prone setup, our data
are consistent with those of other literature series
[2-4,13]. In prone position in fact, lung parenchyma in-
side treatment fields is significantly lower, because of
breast dislocation and substantially no influence of re-
spiratory movements [8]. As a matter of fact, various au-
thors demonstrated that the prone setup drastically
reduces intra-fractional respiratory motion of the chest
wall with good reproducibility, reporting a mean inter-
fraction setup variability of less than 0.1 cm [8,10]. In
our series, all patients showed a significant reduction in
lung dose documented by V20, V10, V5, Dmean and
Dmax. These data suggest that in case of lung as well as
of heart diseases, prone setup could be considered re-
gardless to the presence of pendulous breasts.
Literature data are not univocal about reduction in
heart dose in prone setup. Some studies demonstrated a
reduction in heart mean and maximum doses [2,4],
others showed a higher mean dose to cardiac cavities
Figure 2 Lung mean dose in prone and supine setup.
Table 4 Comparison of heart and left anterior descending
coronary artery (LAD) coronary artery dosimetric
parameters in the 10 patients with left breast cancer
treated with in prone setup
Prone setup Supine setup p-value
Heart (cc) 434.0 ± 92.6 469.3 ± 116.2 0.19
V20 (%) 0.6 ± 1.1 1.9 ± 1.6 0.026
V10 (%) 1.2 ± 1.8 3.1 ± 2.2 0.017
V5 (%) 2.4 ± 2.8 5.5 ± 4.3 0.005
Dmean (Gy) 1.6 ± 0.7 2.3 ± 1.0 0.9008
Dmax (Gy) 31.2 ± 14.0 41.9 ± 11.2 0.005
Dmean LAD (Gy) 9.4 ± 8.4 12.5 ± 9.5 0.03
Dmax LAD (Gy) 23.7 ± 15.2 34.5 ± 12.8 0.006
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prone and supine position [3,13,16]. These discordant
data can be explained if it is considered that in prone
position there is an anterior heart dislocation with a
consequently differences in setup device and technical
modalities of treatment as well as differences in cardiac
cavities contouring and patients characteristics can influ-
ence the distribution of radiation dose [17].
From our analysis it emerged a non-statistically signifi-
cant reduction in heart V5, V10, V20 and Dmax in prone
set-up, but a trend for Dmean. On the contrary, in
23.5% of the patients with left sided cancer, the heart re-
ceived a higher dose in supine setup. Other studies
reported that in about 15% of left sided breast the prone
setup did not present favorable dosimetry for heart pa-
rameters [18,19].
Because of its anatomical position, LAD is frequently
inside treatment fields receiving a not negligible dose.
Nowadays, there is not a reliable dose constraint for
LAD, but there are literature studies that correlated dose
to LAD with cardiac damage and risk of coronary dis-
ease [20]. Controversial opinions about the potential ad-
vantage of prone position for reducing the dose to the
LAD were recently reported [18]. From our data, it
emerged a non-significant reduction in mean and max-
imum dose in prone setup. Interestingly, Dmax to the
LAD in patients with right sided breast cancer was rela-
tively low as expected, but significantly lower in prone
than in supine position.
Reproducibility of the prone versus supine setup pos-
ition was quite similar in our experience. However, a
specific training of the personnel involved is needed be-
cause longer time and more accurate checks arerequired in the first phase when the procedure is
implemented. In our experience, the AlignRT system
was of help in checking the right position of the patients
either in supine or in prone setup. About patients com-
pliance, some studies reported difficulty in prone posi-
tioning especially in elder women [7,9] but most authors
observed that precision and reproducibility of prone
setup was comparable to supine data [8,10,21]. In our
study, only 3.6% of the patients was excluded because of
low compliance to the prone setup.
Women with large and pendulous breasts can be tech-
nically challenging to treat with breast irradiation,
resulting in high rates of severe acute dermatitis and late
fibrosis that may cause unacceptable cosmetic outcome
[22,23]. In the present study, we reported an acceptable
rate of acute and late toxicity, similar to that reported in
other literature studies [7,17].
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small patients number related to the case selection fo-
cused only on pendulous breast patients, the availability of
a CT-scan with small gantry size. Moreover, we did not
consider the dose to contralateral breast; in this regard,
other authors analyzed this parameter and failed to show
any difference between the two setup positions [17].
Conclusion
From our prospective study, the prone position allowed
a significant decrease of ipsilateral lung dose in all pa-
tients and a favorable trend for heart dose in patients
with left sided cancer that became significant in the
group of patients actually treated with prone setup.
Overall, the prone position offered a favorable alterna-
tive for irradiation of pendulous breasts in 71% of the
cases considering our patient selection that excluded the
largest breasts. In clinical practice, the choice of the
treatment position should be based on an accurate ana-
lysis of each individual case.
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